We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
+$137M
Cap. Flow
+$88.8M
Cap. Flow %
3.06%
Top 10 Hldgs %
17.97%
Holding
1,008
New
71
Increased
442
Reduced
400
Closed
82

Top Buys

Rank Stock Value
1
VGM icon
Invesco Trust Investment Grade Municipals
VGM
+$4.8M
2
NMZ icon
Nuveen Municipal High Income Opportunity Fund
NMZ
+$4.39M
3
MQY icon
BlackRock MuniYield Quality Fund
MQY
+$4.26M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.84M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$3.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$19.8M
2
ETNB
89bio
ETNB
+$3.65M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$3.59M
4
RKLB icon
Rocket Lab Corp
RKLB
+$3.39M
5
VMO icon
Invesco Municipal Opportunity Trust
VMO
+$3.16M

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 11.66%
3 Financials 9.01%
4 Industrials 7.22%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBER icon
451
Uber
UBER
$160B
$1.33M 0.05%
16,276
+3,959
+32% +$356K
SCHO icon
452
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
$1.32M 0.05%
54,350
-2,648
-5% -$64.6K
LUNR icon
453
Intuitive Machines
LUNR
$2.64B
$1.32M 0.05%
81,389
-541
-0.7% -$6.27K
ORI icon
454
Old Republic International
ORI
$10.2B
$1.31M 0.05%
28,748
-707
-2% -$30.7K
BYRN icon
455
Byrna Technologies
BYRN
$106M
$1.31M 0.05%
77,801
+10,540
+16% +$205K
SBRA icon
456
Sabra Healthcare REIT
SBRA
$5.07B
$1.31M 0.05%
68,967
+43,615
+172% +$808K
APLS
457
DELISTED
Apellis Pharmaceuticals
APLS
$1.3M 0.05%
51,933
+3,804
+8% +$89.2K
EFC
458
Ellington Financial
EFC
$1.74B
$1.3M 0.05%
95,947
+61,140
+176% +$832K
PFBC icon
459
Preferred Bank
PFBC
$1.26B
$1.29M 0.04%
13,674
+991
+8% +$92.4K
BSJR icon
460
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$882M
$1.29M 0.04%
56,892
-17,087
-23% -$387K
CSWC icon
461
Capital Southwest
CSWC
$1.6B
$1.28M 0.04%
57,913
-3,254
-5% -$68.7K
CLDX icon
462
Celldex Therapeutics
CLDX
$3.48B
$1.28M 0.04%
46,965
+11,182
+31% +$295K
ABT icon
463
Abbott
ABT
$190B
$1.28M 0.04%
10,179
-1,782
-15% -$227K
AFL icon
464
Aflac
AFL
$60.7B
$1.27M 0.04%
11,551
+2,648
+30% +$292K
HAS icon
465
Hasbro
HAS
$13.7B
$1.27M 0.04%
15,478
+6,492
+72% +$509K
DGX icon
466
Quest Diagnostics
DGX
$26.2B
$1.26M 0.04%
7,283
+744
+11% +$135K
TDG icon
467
TransDigm Group
TDG
$68.7B
$1.25M 0.04%
943
-18
-2% -$23.6K
ZVRA icon
468
Zevra Therapeutics
ZVRA
$673M
$1.25M 0.04%
+139,591
New +$1.32M
FPF
469
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
$1.25M 0.04%
67,070
-66,276
-50% -$1.24M
ACHR icon
470
Archer Aviation
ACHR
$5.18B
$1.25M 0.04%
166,107
-13,770
-8% -$130K
ARI
471
Apollo Commercial Real Estate
ARI
$880M
$1.25M 0.04%
128,801
+81,862
+174% +$819K
RL icon
472
Ralph Lauren
RL
$23.7B
$1.24M 0.04%
3,519
-776
-18% -$264K
MSM icon
473
MSC Industrial Direct
MSM
$6.7B
$1.24M 0.04%
14,733
-1,865
-11% -$162K
CAT icon
474
Caterpillar
CAT
$388B
$1.24M 0.04%
2,162
+1,221
+130% +$679K
EXLS icon
475
EXL Service
EXLS
$5.29B
$1.23M 0.04%
28,912
+15,764
+120% +$644K
17 18
19
20 21

Similar funds

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Hennion & Walsh Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Hennion & Walsh Asset Management held 1,008 positions worth $2.9B, up 5% from $2.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $88.8M of net new capital in Q4 2025, opening 71 new positions and adding to 442 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $3.59M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2025 buy was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
  • Hennion & Walsh Asset Management added most to Invesco Trust Investment Grade Municipals in Q4 2025, an estimated $4.8M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2025 reduction was Rhythm Pharmaceuticals, cutting an estimated $3.59M.
  • Hennion & Walsh Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $19.8M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $2.9B portfolio in Q4 2025.
  • Hennion & Walsh Asset Management opened 71 new positions and closed 82 in Q4 2025.
  • Hennion & Walsh Asset Management's portfolio value rose 5% quarter-over-quarter to $2.9B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.